n-benzyloxycarbonylprolylprolinal has been researched along with arginine vasopressin in 1 studies
| Studies (n-benzyloxycarbonylprolylprolinal) | Trials (n-benzyloxycarbonylprolylprolinal) | Recent Studies (post-2010) (n-benzyloxycarbonylprolylprolinal) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 39 | 0 | 7 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | n-benzyloxycarbonylprolylprolinal (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miura, N; Shibata, S; Watanabe, S | 1 |
1 other study(ies) available for n-benzyloxycarbonylprolylprolinal and arginine vasopressin
| Article | Year |
|---|---|
Increase in the septal vasopressin content by prolyl endopeptidase inhibitors in rats.
Topics: Administration, Oral; Animals; Arginine Vasopressin; Dipeptides; Male; Prolyl Oligopeptidases; Rats; Rats, Wistar; Septal Nuclei; Serine Endopeptidases; Serine Proteinase Inhibitors | 1995 |